Author: Bakhshaee, Mehdi; Barzegar-Amini, Maral; Motedayen, Zohreh; Khojasteh-Taheri, Roshanak; Rafiee, Mahdi; Amini, Mahnaz; Layegh, Parvaneh; Hashemzadeh, Kamila; Omidvar, Delaram; Hwang, Peter H.; Hosseinpoor, Masoomeh
Title: Olfactory Dysfunction in Patients Infected with 2019 Novel Coronavirus Cord-id: opsieb6p Document date: 2021_5_25
ID: opsieb6p
Snippet: INTRODUCTION: The current study aimed at investigating the occurrence and features of olfactory dysfunction in patients with confirmed coronavirus disease 2019 (COVID-19) infection. MATERIALS AND METHODS: Patients with laboratory and clinically confirmed COVID-19 infection were enrolled in this longitudinal study. They were managed in either the inpatient or outpatient setting. The demographic, clinical, and outcome data were retrieved from patients’ medical records. Olfactory dysfunction feat
Document: INTRODUCTION: The current study aimed at investigating the occurrence and features of olfactory dysfunction in patients with confirmed coronavirus disease 2019 (COVID-19) infection. MATERIALS AND METHODS: Patients with laboratory and clinically confirmed COVID-19 infection were enrolled in this longitudinal study. They were managed in either the inpatient or outpatient setting. The demographic, clinical, and outcome data were retrieved from patients’ medical records. Olfactory dysfunction features, including the onset pattern, duration, and recovery time were investigated. The visual analog scale (VAS) was utilized as a self-rating subjective measurement of olfactory function. RESULTS: According to the results, the mean age of the patients (n=502) was obtained at 46.8±18.5 years; moreover, 52.4% and 47.6% of cases were female and male, respectively. It was also revealed that 35.4% and 64.5% of the subjects were outpatients and hospitalized, respectively. Based on the findings, 178 (38.4%) subjects had olfactory dysfunction. The mean values of VAS in hyposmic patients were estimated at 2.5±2.5, 8.3 ±2.1, and 9.4±1.6 at the first evaluation, in 2 weeks, and after 1 month of follow-up (P<0.001). The onset of olfactory dysfunction was more suddenly (58.7%). The majority of cases experienced olfactory dysfunction at the same time as other symptoms 72(51.1%). Based on the results, 0.4% of subjects infected with COVID-19 had olfactory dysfunction as an isolated symptom. The olfactory dysfunction was recovered after 2 weeks in 18 (25.3%) anosmic and 37(46.8%) hyposmic patients. CONCLUSION: Olfactory dysfunction seemed to be an important symptom of COVID-19 infection. The occurrence of this disturbance as a transient self-limited condition was significantly higher among female subjects.
Search related documents:
Co phrase search for related documents- abnormal normal and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- abnormal normal and lung involvement: 1, 2, 3, 4, 5
- abnormal normal and lymphocyte count: 1, 2, 3, 4, 5
- acute cardiac injury and long term anosmia: 1
- acute cardiac injury and lung involvement: 1, 2, 3
- acute cardiac injury and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute kidney injury acute cardiac injury and lung involvement: 1, 2
- acute kidney injury acute cardiac injury and lymphocyte count: 1, 2, 3
- acute kidney injury and local inflammation: 1, 2, 3
- acute kidney injury and longitudinal study: 1, 2, 3, 4, 5, 6
- acute kidney injury and low prevalence: 1, 2
- acute kidney injury and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acute kidney injury and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- acute respiratory distress syndrome and local inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute respiratory distress syndrome and long term anosmia: 1
- acute respiratory distress syndrome and longitudinal study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute respiratory distress syndrome and low prevalence: 1, 2, 3, 4, 5, 6
- acute respiratory distress syndrome and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48
- acute respiratory distress syndrome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64
Co phrase search for related documents, hyperlinks ordered by date